Introduction
Malaria continues to be the world's most important protozoan-parasitic infection. It ranks third among major infectious disease with a mortality rate lower only than pneumococcal respiratory infections and tuberculosis 1 . The annual number of cases of clinical malaria worldwide is estimated to be 300 and 500 million, with 1.5 to 2.7 million deaths 2, 3 . Malaria is an important public health problem of Bangladesh with about 80% of the 125 million population at risk for infection with either Plasmodium falciparum (P falciparum) or Plasmodium vivax (P vivax) . Transmission of P falciparum is more focal with an estimated 35 million people at risk and about 10 million people at high risk 4 . Strengthening of national capabilities to provide early diagnosis and treatment both within and outside the general health services is of highest priority in WHO's Action Plan for Malaria Control 1995-2000 5 .
Early diagnosis and prompt treatment is of paramount importance to reduce the mortality and morbidity and also for drug resistance associated with it. The clinical diagnosis of severe malaria can be difficult as there is no component of the clinical picture or its complications that are unequivocally diagnostic of the infection. Microscopic analysis for identifying malaria infections has been done for more than a century. Slides obtained from finger prick blood samples when properly stained and skillfully examined, permit species diagnosis, estimations of parasitaemia, identification of the various blood forms of parasite and often, prognosis of the likely course of disease. The technique is capable of accurate and reliable diagnosis when performed by skilled microscopist using defined protocols. These qualifiers, skill of the microscopist and use of proven, defined procedures frequently present the greatest obstacles to fully achieving the potential accuracy of microscopic diagnosis. Conversely patients with severe malaria are occasionally seen whose blood film at the time of presentation is negative because of previous treatment, a highly synchronous infection, or comprehensive sequestration of parasitized erythrocytes in deep vascular beds. Yet the simplest and surest test is the time honoured peripheral smear study for malarial parasites.
However, difficulty in maintaining required technical skills and infrastructure has spurred the development of several non-microscopic malaria rapid diagnostic devices (MRDDs). The patients were treated according to the National Guidelines i.e. parenteral quinine followed by oral quinine whenever patients could take orally. Dose of quinine was 10 mg/kg/dose (quinine dihydrochloride) as salt in isotonic fluid (5% dextrose water/saline) 500 ml over 3-4 hours and repeated 8 hourly. Quinine therapy was continued for a total of 7 days. Other general and specific measures, such as 25% glucose for suspected/proved hypoglycaemia, blood transfusion for severe anaemia. Intravenous diazepam and anticonvulsant, peritoneal dialysis (for selected patients) were taken when appropriate. Outcome of severe Malaria was categorized as full recovery, recovery with complication, death and others.
Results
In this study, age range was from 12 to 65 years. Out of 106 cases, 69 (65%) patients were aged below 30 years (Table I ). This study included 83 male (78.3%) and 23 (21.7%) female patients with ratio of 3.6:1. Out of 23 female patients, 5 patients were pregnant. Two of them died and one had abortion. Thirty six patients (34%) have residence in malaria endemic zone (Table II) and 69 (55.1%) patients had history of taking antimalarial drugs before hospitalization. Paracheck Pf (Orchid Biomedical Systems, India) is a rapid self performing qualitative, two site sandwich invitro immunoassay for the detection of circulating P falciparum Histidine rich protein-2 (Pf HRP-2), is a water soluble protein that is released from parasitized erythrocytes and is specific to the P falciparum species 6, 7 . The test uses two antibodies specific for Pf HRP-2 antigen. One of the antibodies is attached to visible colloidal gold and impregnated into a sample pad, while the second antibody is immobilized as a line across the test strip. In a positive sample, Pf HRP-2 complexed with the gold labeled antibody is captured by the antibody on the membrane and a pink line forms. In a negative sample, no pink line forms. It is rapid, cost effective and doesn't require specialized equipment. Test can be carried out at the point of contact between the patient and the health care worker 8 .
The reported study was conducted to observe the advantage of immunochromatographic test over microscopic peripheral smear in clinically suspected severe malaria cases. o F) was present among 5 hospitalized patients, 3 of them died. The other clinical presentations accordingly were vomiting (71%), severe prostration (67%), dark coloured urine (67.9%), oliguria (18%), deep breathing (21%), hepatomegaly (68%), splenomegaly (51%), rousable coma (31%) and unrousable coma (28.3%). Patients with low Glasgow come score at presentation during hospitalization was associated with poor outcome. Fifty five percent of patients who died have GCS < 7. Similar report was also documented in a study by Faiz et al 9 .
Materials and Methods
Anaemia was found in 67% patients, among these, 8 patients (7.5%) patients had haemoglobin below 5 gm/dl i.e. severe anaemia. Out of these 8 patients, 2 died which indicate severe anaemia is a poor prognostic factor. Jaundice was present in 57 (53%) of patients. Seven out of 9 patients who died had jaundice. However, death rate was high in patients with associated renal failure (55%) and deep breathing (52%). This is consistent with the findings of acute renal failure in malaria by Chowdhury et al 10 .
Microscopic peripheral smear study for malarial parasite was positive in 74 (69.8%) patients. Malarial parasite count varies from 100/cu mm to 25 x 10 5 /cu mm (mean ± SD = 215. 21 ± 446. 74 per cumm). Seventy three of these patient's slide show P falciparum, where as 1 patient had P vivax. Immunochromatographic Paracheck Pf test was positive in 96 (90.6%) patients. Paracheck Pf test was positive in all but 1 slide positive malaria cases. The only slide positive case which Paracheck Pf test fail to detect was P vivax. Which is consistent with its principle as Paracheck Pf detect only HRP-2 released from P falciparum infected cells. It can be deduced from here that diagnostic capability of Immunono- It was observed that patients recovered fully had mean Glasgow coma score (GCS) 11.13 ± 3.63; where as 8.88 ± 2.89 was the mean score for the patient died during treatment. Anaemia, thrombocytopenia, hypoglycemia, mild renal impairment were observed in investigation in this study (Table IV) .
Table -IV: Findings of laboratory investigation (n=106)
Among 106 patents, microscopy was positive in 74 (69.8%) cases with variable range and Parcheck Pf test was positive in 96 (90.6%) cases. Out of the microscopically positive cases, 73 cases were P falciparum and 1 case was P vivax. Out of those patients Paracheck Pf test was positive in 73 cases. Among 32 (30.2%) microscopic negative cases, 9 (28.1%) cases were negative both in malarial microscopy and Parachek Pf test. The other 23 (71.9%) cases were positive for Paracheck Pf test but negative for malarial microscopy. Out of these 23 cases 20 had prior history of antimalarial drug intake before hospitalization. 
Conclusion
In contrast to light microscopy, Paracheck Pf test is fast and simple. One test can be completed in less than 15 minutes and many can be done simultaneously, reducing the time required for the results to be made available to support the clinical diagnosis, if accuracy can be assured and the test made affordable for those in need.
Both the specificity and sensitivity of the Paracheck Pf when measured against current "gold standards "are generally around 90%. This is considered to be at least equal to that currently achieved in well organized malaria diagnostic laboratories, and probably well in excess of that achieved in many general health services, particularly those at the periphery.
A potential problem with the Paracheck Pf is that circulating antigen may be detected after elimination of viable parasites from the blood stream. However, these antigenaemic patients were usually clinically asymptomatic after clearance of the parasitaemias. Thus,
